GSK said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in ...

The NHS says the RSV vaccine is recommended from 28 weeks of pregnancy, to protect the baby for the first few months after ...

Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among adults so far this respiratory ...

Winter and family holiday gatherings often bring a surge in a wide variety of respiratory issues. Here's what to watch for.

A new Centers for Disease Control and Prevention (CDC) report reveals low uptake of flu, COVID-19 and respiratory syncytial ...

GSK has received approval from Japan's MHLW for its application to extend the indication of its RSV vaccine, Arexvy.

COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among nursing home residents e ...

Effectiveness of Maternal Vaccination to Prevent Respiratory Syncytial Virus Illness,” published in the November 2024 issue ...

Zuo is a public health resident at the University of British Columbia who works with Northern Health’s medical health ...

Significant gaps in vaccination coverage among nursing home residents leaves vulnerable populations at risk for severe ...

Local coronavirus cases have been flat, likely due to the outsized surge that occurred this past summer, but the flu appears ...